What is the recommended treatment plan for a patient with costochondritis?

Treatment of Costochondritis

Start with NSAIDs or COXIBs at maximum tolerated and approved dosage as first-line treatment, evaluate response at 2-4 weeks, and add non-pharmacological interventions including local heat/cold application and stretching exercises. 1

First-Line Pharmacological Management

NSAIDs/COXIBs

• Initiate NSAIDs or COXIBs at maximum tolerated and approved dosage as the primary treatment for costochondritis 1
• Use oral NSAIDs at the lowest effective dose for the shortest possible period to minimize gastrointestinal, hepatic, and cardiorenal toxicity 1
• Consider topical NSAIDs as an alternative to minimize systemic side effects, particularly in elderly patients or those with comorbidities 1
• For patients with increased gastrointestinal risk, use non-selective NSAIDs plus a gastroprotective agent (proton pump inhibitor), or a selective COX-2 inhibitor 1

Acetaminophen (Paracetamol)

• Regular dosing of acetaminophen may be needed as an alternative or adjunct when NSAIDs are insufficient, contraindicated, or poorly tolerated 1

Treatment Response Evaluation

• Evaluate treatment response at 2-4 weeks 1
• If sufficient response: continue treatment and re-evaluate at 12 weeks; consider tapering or on-demand treatment if sustained improvement 1
• If insufficient response at 2-4 weeks: consider switching to a different NSAID or adding acetaminophen 1

Non-Pharmacological Interventions

Physical Modalities

• Apply local heat or cold applications to the affected costochondral area 1
• Implement stretching exercises targeting the chest wall musculature, which have shown progressive significant improvement in pain reduction (p<0.001) 2
• Consider physical therapy and osteopathic manipulation techniques for rib dysfunction, particularly in cases not responding to initial treatment 3

Patient Education

• Provide patient education about the benign, self-limiting nature of costochondritis to reduce psychological burden 1
• Advise patients to avoid activities that produce chest muscle overuse 4

Bridging and Adjunctive Options

Corticosteroid Use

• Short courses of oral prednisolone or local corticosteroid injections directed to the specific costochondral junction may be considered as bridging options while awaiting the effect of other agents 1
• Local injections are appropriate for persistent focal pain despite adequate NSAID therapy 1
• Avoid long-term use of systemic glucocorticoids due to lack of evidence supporting their use and significant adverse effect profile 1

Critical Safety Considerations

Cardiac Exclusion

• Rule out serious cardiac causes before diagnosing costochondritis, as coronary artery disease is present in 3-6% of adult patients with chest pain and chest wall tenderness 4
• Patients older than 35 years, those with cardiac risk factors, or any cardiopulmonary symptoms should have electrocardiogram and possibly chest radiograph 4
• History and physical examination documenting reproducible pain by palpation over costal cartilages is usually sufficient for diagnosis in children, adolescents, and young adults 4

NSAID Monitoring

• Monitor for gastrointestinal, hepatic, and cardiorenal toxicity with prolonged NSAID use, particularly in elderly patients and those with comorbidities 1
• Selective COX-2 inhibitors reduce serious gastrointestinal risk with relative risk 0.18 (95% CI: 0.14-0.23) compared to non-selective NSAIDs 1

Common Pitfalls to Avoid

• Do not use long-term systemic corticosteroids as they lack evidence and carry significant adverse effects 1
• Do not overlook infectious costochondritis in patients with diabetes, immunosuppression, or recent surgery who present with persistent symptoms, purulent drainage, or systemic signs of infection 5
• Do not dismiss atypical costochondritis (symptoms persisting beyond several weeks) as purely psychosomatic; consider multimodal approaches including manipulation and soft tissue mobilization 3